ClinConnect ClinConnect Logo
Search / Trial NCT06608524

Effect of Self-regulated Learning on Academic Performance Among Physical Education Students

Launched by XIE HUIJUAN · Sep 19, 2024

Trial Information

Current as of August 19, 2025

Enrolling by invitation

Keywords

Self Regulated Learning Academic Performance Physical Education

ClinConnect Summary

In this study, the experimental group received a 12-week (John, 2017) self-regulated learning strategy based on a learning model teaching intervention designed for this study. In contrast, the control group discussed and studied traditional learning content for 12 weeks with the teacher, and the students in the experimental group learned the self-regulated learning strategy. A cluster-randomised controlled trial (CRCT) design was used, and the experimental and control groups were randomly assigned to two schools. After 12 weeks of learning, both groups were required to conduct a learning pe...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. University students;
  • 2. Major in Physical Education;
  • 3. Health;
  • 4. Able to attend all evaluation;
  • 5. Understand the study purposes and procedures;
  • 6. No previous experience performing self-regulated learning strategy.
  • Exclusion Criteria:
  • 1. University students not majoring in Physical Education;
  • 2. Exclude participants who have not finished all evaluation;
  • 3. Not understanding the study purposes and procedures;
  • 4. Participants with an experience in self-regulated learning strategy.

About Xie Huijuan

Xie Huijuan is a dedicated clinical trial sponsor with a strong commitment to advancing medical research and improving patient outcomes. With extensive experience in the design and execution of clinical studies, the organization focuses on innovative therapies and cutting-edge technologies across various therapeutic areas. Xie Huijuan prioritizes collaboration with healthcare professionals and regulatory bodies to ensure the highest standards of ethical compliance and scientific rigor. By fostering a patient-centered approach, the sponsor aims to contribute meaningful data that enhances the understanding of treatment efficacy and safety, ultimately driving the development of new healthcare solutions.

Locations

Yuncheng, Shanxi, China

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported